Interferon Pharmaceuticals Private Limited
About Interferon Pharmaceuticals Private Limited
Data last updated:
Interferon Pharmaceuticals Private Limited is a private limited company based in Cooch Behar, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2016PTC215944. Its GSTIN is 19AAECI1854P1Z0 (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.91 Lakh. It is led by directors including Goutam Kumar Dey and Goutam Saha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor P.O. Ghugumari Ps: Kotwali, Cooch Behar, West Bengal, India – 736170.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.04 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹73,473 (net margin 1.1%) and EBITDA of ₹3.35 Lakh (EBITDA margin 4.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGround Floor P.O. Ghugumari Ps: Kotwali, Cooch Behar, West Bengal, India – 736170
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Interferon Pharmaceuticals Private Limited
The main business activity of Interferon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Interferon Pharmaceuticals Private Limited FY 2025 filings available
Interferon Pharmaceuticals Private Limited reported revenue of ₹68.04 Lakh (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Interferon Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 22% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Interferon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹73,473 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Interferon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Interferon Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vet Medicure Solutions Private Limited | ₹68.17 Lakh (FY 2023) | •••• | •••• | -61.0% | •••• | Delhi, India |
| Janani Pharmaceuticals Private Limited | ₹68.11 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Chennai, Tamil Nadu, India |
| Dhrumentis Pharmaceuticals Private Limited | ₹68.07 Lakh (FY 2025) | •••• | •••• | 685.0% | •••• | Khalilabad, Uttar Pradesh, India |
| Omarion Pharmaceuticals Private Limited | ₹68.06 Lakh (FY 2025) | •••• | •••• | •••• | Dadri, Uttar Pradesh, India | |
| Virani Pharma Private Limited | ₹68.05 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Bhayander, Maharashtra, India |
| Interferon Pharmaceuticals Private Limited this company | ₹68.04 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | Cooch Behar, West Bengal, India |
| Halmak Pharmaceuticals Private Limited | ₹68.03 Lakh (FY 2015) | •••• | •••• | 16.0% | •••• | Telangana, India |
| Anala Pharmaceuticals Pvt Ltd | ₹67.97 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Thrissur, Kerala, India |
| Mundial Pharmaceuticals Private Limited | ₹67.9 Lakh (FY 2025) | •••• | •••• | -44.0% | •••• | Mumbai, Maharashtra, India |
| Altron Pharmaceuticals Private Limited | ₹67.89 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Mumbai, Maharashtra, India |
| Nexokinde Healthcare Private Limited | ₹67.89 Lakh (FY 2025) | •••• | •••• | -45.0% | •••• | Moradabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Interferon Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals Private Limited is audited by H K CHAKI & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H K CHAKI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goutam Kumar Dey | Director | 26 May 2016 | 10 Years 4 Months | Current |
| Goutam Saha | Director | 26 May 2016 | 10 Years 4 Months | Current |
| Manash Chakraborty | Director | 26 May 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Interferon Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Interferon Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Interferon Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Kaushik Das ceased to be Director on 09 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts for Interferon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Interferon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Interferon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAECI1854P1Z0 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Interferon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Interferon Pharmaceuticals Private Limited
Interferon Pharmaceuticals is an active private limited company based in Cooch Behar, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 2016 (10+ years old) and is registered under CIN U51909WB2016PTC215944.
Interferon Pharmaceuticals reported revenue of ₹68.04 Lakh for FY 2025 (up 22% YoY).
Interferon Pharmaceuticals has 3 current directors:
- Goutam Kumar Dey - Director
- Goutam Saha - Director
- Manash Chakraborty - Director
Interferon Pharmaceuticals reported a net profit of ₹73,473 (net margin 1.1%) and EBITDA of ₹3.35 Lakh (EBITDA margin 4.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Interferon Pharmaceuticals is 15% over three years and 5% over five years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Interferon Pharmaceuticals is 19AAECI1854P1Z0, registered in West Bengal.
The CIN (Corporate Identification Number) of Interferon Pharmaceuticals is U51909WB2016PTC215944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Interferon Pharmaceuticals was incorporated on 26 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Interferon Pharmaceuticals by revenue are Vet Medicure Solutions Private Limited, Janani Pharmaceuticals Private Limited, Dhrumentis Pharmaceuticals Private Limited, Omarion Pharmaceuticals Private Limited, Virani Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Kaushik Das ceased to be Director on 09 Apr 2019. Goutam Kumar Dey was appointed as Director on 26 May 2016. Goutam Saha was appointed as Director on 26 May 2016. Interferon Pharmaceuticals has 4 board changes on record in total.
The registered office of Interferon Pharmaceuticals is at Ground Floor P.O. Ghugumari Ps: Kotwali, Cooch Behar, West Bengal, India – 736170.